Who we are
Åbo Akademi University (ÅAU) is an internationally acknowledged research university with an extensive responsibility for providing education in Swedish in Finland.
ÅAU has identified three focal areas of research: Minority research, Molecular process and material technology, and Drug development and diagnostics.
In the field of molecular process and material technology, research is conducted, for example, on the production techniques of environmentally-friendly chemicals, health-promoting substances and fuel components.
Drug development and diagnostics is an area of research in which ÅAU is investing jointly with the University of Turku with many exciting projects underway, including basic research in cell biology to support drug development, nanotechnology to find innovative solutions for diagnostics, and new techniques such as 3D printing to produce drugs. The attempt is also to find more targeted selective’ drugs, which may, among other things, facilitate a more gentle, yet effective, cancer treatment.
In addition to this Åbo Akademi University takes part in the Centre of Excellence for Cardiovascular and Metabolic Disease (2014–2019), a joint research project together with the University of Turku, the Central University Hospital of Turku and the University of Eastern Finland.
Another Research Centre of Excellence (2015–2018) at the Abo Akademi University is the BrainTrain project, that studies working memory training, its cognitive and neural mechanisms, and the mental architecture of executive functions. A related research topic is executive functioning in bilingualism.
Åbo Akademi University is also a part of the Health Campus Turku, the largest multi-professional education cluster in medicine and health sciences in Finland. The Hospital District of Southwest Finland, the University of Turku, Åbo Akademi University, Turku University of Applied Sciences and Novia University of Applied Sciences are actively developing the services and operations in the area.
ÅAU actively develops the relationships with business life and maximises the societal and commercial benefits of innovations made at ÅAU, through efficient technology transfer processes. One venture is being a part of the Life Science Accelerator. The accelerator is a new, joint project to help research projects and start-ups towards commercial success. The accelerator focuses on pharma, diagnostics or related areas, and is coordinated by Turku Science Park.
Some examples of innovations and spinoffs at ÅAU: http://web.abo.fi/aktuellt/aau_innovations_spinoffs.pdf